Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma (Skin)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05867303
What this trial is testing

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
MelanomaUrothelial CarcinomaRenal Cell Carcinoma+3 more
RemeGen Co., Ltd. 48
Early research (Phase 1)Not Yet RecruitingNCT07272642
What this trial is testing

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
ImagingColorectal CancerHead and Neck Squamous Cell Carcinoma+2 more
Radiopharm Theranostics, Ltd 16
Testing effectiveness (Phase 2)Looking for participantsNCT07109726
What this trial is testing

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer+5 more
Terremoto Biosciences Inc. 205
Not applicableUnknownNCT03069846
What this trial is testing

Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope

Who this might be right for
Skin Cancer
Sung Hyun Pyun 150
Large-scale testing (Phase 3)Study completedNCT04157985
What this trial is testing

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNSCLCBladder Cancer+10 more
Dan Zandberg 161
Early research (Phase 1)Study completedNCT04121286
What this trial is testing

JAB-3312 in Adult Patients With Advanced Solid Tumors in China

Who this might be right for
Non-small Cell Lung CancerColorectal CancerPancreatic Ductal Carcinoma+4 more
Allist Pharmaceuticals, Inc. 17
Testing effectiveness (Phase 2)UnknownNCT03666325
What this trial is testing

Immunotherapy +/- EGFR Inhibitor In Advanced/Metastatic cSCC: Tackling Primary And Secondary Resistance

Who this might be right for
Skin Neoplasm
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43
Not applicableStudy completedNCT00046189
What this trial is testing

Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum

Who this might be right for
Xeroderma PigmentosumBasal Cell CarcinomaSquamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 301
Early research (Phase 1)Active Not RecruitingNCT05215574
What this trial is testing

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 130
Early research (Phase 1)Study completedNCT06014086
What this trial is testing

Intratumoral PH-762 for Cutaneous Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the SkinMalignant Melanoma of SkinMerkel Cell Carcinoma of Skin
Phio Pharmaceuticals Inc. 22
Early research (Phase 1)Study completedNCT01831089
What this trial is testing

Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors

Who this might be right for
Breast CancerOvarian CancerGynecological Cancer+4 more
PharmaMar 69
Large-scale testing (Phase 3)Looking for participantsNCT06585410
What this trial is testing

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma (CSCC)
Regeneron Pharmaceuticals 369
Not applicableLooking for participantsNCT07337161
What this trial is testing

Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma

Who this might be right for
CutaneousHead and Neck Cancer Squamous Cell Carcinoma
David Palma 90
Testing effectiveness (Phase 2)Study completedNCT00021294
What this trial is testing

Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis

Who this might be right for
Non-melanomatous Skin CancerPrecancerous/Nonmalignant Condition
University of Arizona
Early research (Phase 1)Ended earlyNCT04762225
What this trial is testing

RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanomaCervical Cancer
Repertoire Immune Medicines 7
Early research (Phase 1)WithdrawnNCT02567396
What this trial is testing

Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Who this might be right for
Estrogen Receptor NegativeHead and Neck Squamous Cell CarcinomaHER2/Neu Negative+20 more
National Cancer Institute (NCI)
Not applicableUnknownNCT02352428
What this trial is testing

Skin Cancer Screening Education Study

Who this might be right for
Skin TumorsMelanomaBasal Cell Carcinoma+1 more
Association of Dermatological Prevention, Germany 113
Not applicableStudy completedNCT04389112
What this trial is testing

Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions

Who this might be right for
Cutaneous Squamous Cell CarcinomaBasal Cell Carcinomas
University Hospital, Bordeaux 119
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Early research (Phase 1)Study completedNCT02315066
What this trial is testing

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

Who this might be right for
Neoplasms
Pfizer 174
Next Page